SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today reported financial results for the quarter ended ...

The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...

"Generic drugs are used around the world. There are no doubts about their safety and efficacy as they have undergone ...

GSK plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization, STAT writes.